Coral and Coral-Associated Microorganisms: Source of New Anti-inflammatory Compounds

A special issue of Marine Drugs (ISSN 1660-3397).

Deadline for manuscript submissions: closed (31 October 2021) | Viewed by 381

Special Issue Editors

Graduate Institute of Natural Products, College of Medicine, Chang Gung University, Taiwan;
Research Center for Chinese Herbal Medicine, College of Human Ecology, Chang Gung University of Science and Technology, Taiwan
Interests: neutrophilic inflammation; innate immunity; signal transduction; protein kinase; drug research and development
Special Issues, Collections and Topics in MDPI journals
Program in the Clinical Drug Development of Herbal Medicine, Taipei Medical University, Taipei 11031, Taiwan
Interests: natural products chemistry; mass spectrometry-based metabolomics; pharmacognosy
Special Issues, Collections and Topics in MDPI journals

Special Issue Information

Dear Colleagues,

Inflammation is a very complex combination of physiological and pathological responses. Inflammation helps the immune system defend against microbial infection, but overwhelming inflammatory responses damage cells and tissues, resulting in acute and chronic inflammatory diseases as well as autoimmune disorders. Therefore, the tight regulation of inflammatory responses is a very important issue for human health. Marine natural products have diverse chemical structures that provide novel sources for developing anti-inflammatory drugs. Over the last few decades, there have been significant advances in characterizing anti-inflammatory lead compounds from natural resources. This Special Issue aims to publish research focusing on the identification of novel anti-inflammatory compounds from coral and coral-associated micro-organisms along with the in-depth study of their pharmacological mechanisms.

Prof. Dr. Tsong-Long Hwang
Prof. Dr. Kuei-Hung Lai
Guest Editors

Manuscript Submission Information

Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.

Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Marine Drugs is an international peer-reviewed open access monthly journal published by MDPI.

Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2900 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.

Keywords

  • acute inflammatory disease
  • anti-inflammatory compounds
  • autoimmune disorders
  • chronic inflammatory disease
  • coral
  • coral-associated micro-organisms
  • marine natural products
  • immune
  • inflammation
  • pharmacological mechanisms

Published Papers

There is no accepted submissions to this special issue at this moment.
Back to TopTop